Evaluate mobile medical app compliance with FDA guidance, 21 CFR Part 11, data security, clinical validation, and app store requirements
FDA regulates apps that: diagnose disease, treat/cure disease, prevent disease, affect structure/function of body
Classification determines regulatory pathway: Class I (general controls), Class II (510k), Class III (PMA)
FDA enforcement discretion for wellness apps (general fitness, healthy eating) vs. medical device apps
Algorithm validation, accuracy studies, clinical outcomes data for intended use
Labeling specifies patient population, clinical conditions, intended use statement
Algorithms based on clinical guidelines, peer-reviewed literature, expert consensus
AES-256 encryption for stored data, TLS 1.2+ for network transmission
BAA with AWS, Azure, Google Cloud, or other hosting/storage providers handling PHI
MFA for clinician accounts, biometric or strong passwords for patients
21 CFR Part 11: E-signatures legally binding, audit trail of signer identity, date/time
Part 11.10: Audit trail for record creation, modification, deletion; immutable timestamps
Validation protocol, test scripts, validation report demonstrating system performs as intended
21 CFR Part 820: Design controls, CAPA, document control, management review
Risk analysis, risk evaluation, risk control measures, residual risk acceptance
Regression testing, validation protocol, traceability to requirements, release notes
MDR reporting (deaths, serious injuries within required timeframes), complaint handling
Crash analytics, error rates, user feedback, clinical accuracy monitoring
App store privacy policies, data use disclosures, age ratings, medical device registration
Please answer all required questions to see your results